How Investors Are Reacting To Wesfarmers (ASX:WES) Doubling Mt Holland Lithium Output Plan

• Sociedad Química y Minera de Chile S.A. and Wesfarmers Limited have approved a major expansion of the Mt Holland lithium project, aiming to double annual spodumene concentrate output to about 760,000 tonnes at 5.5% Li2O, backed by a second concentrator and new integrated ore sorting facility, with most government and regulatory approvals secured or underway.
• The expansion, with SQM’s estimated capital spend of US$450 million to US$500 million, materially increases Covalent Lithium’s production optionality, supporting either additional downstream processing at the Kwinana refinery or higher sales of spodumene concentrate into global lithium markets.
• We’ll now examine how this decision to double Mt Holland’s spodumene output could reshape Wesfarmers’ investment narrative, especially around diversification.

We've uncovered the 3 dividend fortresses yielding 5%+ that don't just survive market storms, but thrive in them.

Wesfarmers Investment Narrative Recap

To own Wesfarmers, you need to be comfortable with a primarily Australia and New Zealand retail group that is selectively investing in new growth platforms like lithium and healthcare. The Mt Holland expansion strengthens the longer term diversification story, but it does not change that the key near term catalyst remains execution in core retail (especially Bunnings and Kmart) while the biggest current risk is cost inflation and mixed demand across those same businesses.

The most relevant prior announcement here is the June 2026 decision to fold Blackwoods and Workwear Group into Bunnings. That move highlighted Wesfarmers’ focus on tightening industrial efficiency and sharpening Bunnings’ proposition at a time when the group was already facing cost pressures and cyclical softness in some industrial segments. Set alongside the lithium expansion, it underlines how much the near term story still rests on disciplined execution in the core while newer growth options are being built out.

Yet investors should be aware that cost pressures and execution risk around these growth projects could...

Read the full narrative on Wesfarmers (it's free!)

Wesfarmers’ narrative projects A$52.8 billion revenue and A$3.5 billion earnings by 2029. This requires 4.4% yearly revenue growth and about A$0.4 billion earnings increase from A$3.1 billion today.

Uncover how Wesfarmers' forecasts yield a A$76.16 fair value, a 17% downside to its current price.

Exploring Other Perspectives

Some of the lowest ranked analysts were already more cautious, assuming revenue of about A$52.6 billion and earnings of roughly A$3.3 billion by 2029, so if you are worried about higher wage and sustainability costs on top of Mt Holland execution risk, their more pessimistic view shows just how far opinions can differ and why it is worth weighing several angles before you decide what this expansion might mean for Wesfarmers’ future.

Explore 7 other fair value estimates on Wesfarmers - why the stock might be worth as much as A$89.00!

Reach Your Own Conclusion

Don't just follow the ticker - dig into the data and build a conviction that's truly your own.

• A great starting point for your Wesfarmers research is our analysis highlighting 2 key rewards and 1 important warning sign that could impact your investment decision.
• Our free Wesfarmers research report provides a comprehensive fundamental analysis summarized in a single visual - the Snowflake - making it easy to evaluate Wesfarmers' overall financial health at a glance.

Looking For Alternative Opportunities?

Don't miss your shot at the next 10-bagger. Our latest stock picks just dropped:

• AI is about to change healthcare. These 8 stocks are working on everything from early diagnostics to drug discovery. The best part - they are all under $10b in market cap - there's still time to get in early.
• Explore 26 top quantum computing companies leading the revolution in next-gen technology and shaping the future with breakthroughs in quantum algorithms, superconducting qubits, and cutting-edge research.
• The future of work is here. Discover the 36 top robotics and automation stocks leading the charge in AI-driven automation and industrial transformation.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com